Stay updated on Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial page.

Latest updates to the Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check111 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial page.